Have a personal or library account? Click to login
Open Access
|Aug 2020

References

  1. 1. SINGER M., DEUTSCHMAN CS., SEYMOUR C.W., SHANKAR-HARI M., ANNANE D., BAUER M., BELLOMO R., BERNARD GR., CHICHE JD., COOPERSMITH C.M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 2016; 315(8):801–810.10.1001/jama.2016.0287496857426903338
  2. 2. FLEISCHMANN C., SCHERAG A., ADHIKARI NK, HARTOG CS., TSAGANOS T., SCHLATTMANN P., ANGUS DC., REINHART K. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med 2016; 193(3):259–272.10.1164/rccm.201504-0781OC26414292
  3. 3. DELLINGER RP., CARLET JM., MASUR H., GERLACH H., CALANDRA T., COHEN J., GEA-BANACLOCHE J., KEH D., MARSHALL JC., PARKER MM. et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32(3):858–873.10.1097/01.CCM.0000117317.18092.E415090974
  4. 4. AMERICAN COLLEGE OF CHEST PHYSICIANS/SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20(6):864–874.10.1097/00003246-199206000-00025
  5. 5. PRO CI., YEALY DM., KELLUM JA., HUANG DT., BARNATO AE., WEISSFELD LA., PIKE F., TERNDRUP T., WANG HE., HOU PC. et al. A randomized trial of protocol-based care for early septic shock. The New England journal of medicine 2014; 370(18):1683–1693.10.1056/NEJMoa1401602410170024635773
  6. 6. MOUNCEY PR., OSBORN TM., POWER GS., HARRISON DA., SADIQUE MZ., GRIEVE RD., JAHAN R., HARVEY SE., BELL D., BION JF. et al: Trial of early, goal-directed resuscitation for septic shock. The New England journal of medicine 2015; 372(14):1301–1311.10.1056/NEJMoa150089625776532
  7. 7. PEAKE SL., DELANEY A., BAILEY M., BELLOMO R., CAMERON PA., COOPER DJ., HIGGINS AM., HOLDGATE A. et al. Goal-directed resuscitation for patients with early septic shock. The New England journal of medicine. 2014; 371(16):1496–1506.10.1056/NEJMoa140438025272316
  8. 8. CHURPEK MM., ZADRAVECZ FJ., WINSLOW C., HOWELL MD., EDELSON DP. Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients. Am J Respir Crit Care Med. 2015; 192(8):958–964.10.1164/rccm.201502-0275OC464220926158402
  9. 9. SEYMOUR CW., KENNEDY JN., WANG S., CHANG CH., ELLIOTT CF., XU Z., BERRY S., CLERMONT G., COOPER G., GOMEZ H. et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019; 321(20):2003–2017.10.1001/jama.2019.5791653781831104070
  10. 10. KUMAR A., ROBERTS D., WOOD KE., LIGHT B., PARRILLO JE., SHARMA S., SUPPES R., FEINSTEIN D., ZANOTTI S., TAIBERG L. et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596.10.1097/01.CCM.0000217961.75225.E916625125
  11. 11. KOVACH CP., FLETCHER GS., RUDD KE., GRANT RM., CARLBOM DJ. Comparative prognostic accuracy of sepsis scores for hospital mortality in adults with suspected infection in non-ICU and ICU at an academic public hospital. PloS one 2019, 14(9):e0222563.10.1371/journal.pone.0222563674650031525224
  12. 12. ANAND V., ZHANG Z., KADRI SS., KLOMPAS M., RHEE C., PROGRAM CDCPE: Epidemiology of Quick Sequential Organ Failure Assessment Criteria in Undifferentiated Patients and Association With Suspected Infection and Sepsis. Chest 2019; 156(2):289–297.10.1016/j.chest.2019.03.032685924530978329
  13. 13. THWAITES CL., LUNDEG G., DONDORP AM. Sepsis in resource-limited settings-expert consensus recommendations group of the European Society of Intensive Care M, the Mahidol-Oxford Research Unit in Bangkok T: Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings. Intensive care medicine 2016; 42(12):2040–2042.10.1007/s00134-016-4415-3510649327324344
  14. 14. BONE RC., BALK RA., CERRA FB., DELLINGER RP., FEIN AM., KNAUS WA., SCHEIN RM., SIBBALD WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101(6):1644–1655.
  15. 15. SEYMOUR CW., LIU VX., IWASHYNA TJ., BRUNKHORST FM., REA TD., SCHERAG A., RUBENFELD G., KAHN JM., SHANKAR-HARI M., SINGER M et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315(8):762–774.10.1001/jama.2016.0288543343526903335
  16. 16. SMITH GB., PRYTHERCH DR., MEREDITH P., SCHMIDT PE., FEATHERSTONE PI. The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation 2013; 84(4):465–470.10.1016/j.resuscitation.2012.12.01623295778
  17. 17. LIU VX., FIELDING-SINGH V., GREENE JD., BAKER JM., IWASHYNA TJ., BHATTACHARYA J., ESCOBAR GJ. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am J Respir Crit Care Med. 2017; 196(7):856–863.10.1164/rccm.201609-1848OC564997328345952
  18. 18. LEVY MM., EVANS LE., RHODES A. The Surviving Sepsis Campaign Bundle: 2018 Update. Crit Care Med 2018; 46(6):997–1000.10.1097/CCM.000000000000311929767636
  19. 19. STERLING SA., MILLER WR., PRYOR J., PUSKARICH MA., JONES AE. The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Crit Care Med. 2015; 43(9):1907–1915.10.1097/CCM.0000000000001142459731426121073
  20. 20. FILBIN MR., THORSEN JE., ZACHARY TM., LYNCH JC., MATSUSHIMA M., BELSKY JB., HELDT T., REISNER AT. Antibiotic Delays and Feasibility of a 1-Hour-From-Triage Antibiotic Requirement: Analysis of an Emergency Department Sepsis Quality Improvement Database. Annals of emergency medicine. 2020; 75(1):93–99.10.1016/j.annemergmed.2019.07.01731561998
  21. 21. CHENG MP., STENSTROM R., PAQUETTE K., STABLER SN., AKHTER M., DAVIDSON AC., GAVRIC M., LAWANDI A., JINAH R., SAEED Z. et al. Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study. Ann Intern Med. 2019; 171(8):547–554.10.7326/M19-169631525774
  22. 22. BOUZA E., SOUSA D., RODRIGUEZ-CREIXEMS M., LECHUZ JG., MUNOZ P. Is the volume of blood cultured still a significant factor in the diagnosis of bloodstream infections? Journal of clinical microbiology 2007; 45(9):2765–2769.
  23. 23. KEE PP., CHINNAPPAN M., NAIR A., YEAK D., CHEN A., STARR M., DALEY AJ., CHENG AC., BURGNER D. Diagnostic Yield of Timing Blood Culture Collection Relative to Fever. The Pediatric infectious disease journal. 2016; 35(8):846–850.10.1097/INF.000000000000118927164461
  24. 24. LEE A., MIRRETT S., RELLER LB., WEINSTEIN MP. Detection of bloodstream infections in adults: how many blood cultures are needed? Journal of clinical microbiology. 2007; 45(11):3546–3548.10.1128/JCM.01555-07216849717881544
  25. 25. PITTET D., MENICHETTI F., ANTUNES F., GARAU J., GRANINGER W., GRUNEBERG RN., PEETERMANS WE., SHAH PM. Empirical antibacterial treatment for sepsis and the role of glycopeptides: recommendations from a European panel. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 1997; 3(3):273–282.10.1111/j.1469-0691.1997.tb00614.x11864121
  26. 26. METLAY JP., WATERER GW., LONG AC., ANZUETO A., BROZEK J., CROTHERS K., COOLEY LA., DEAN NC., FINE MJ., FLANDERS SA. et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019; 200(7):e45–e67.10.1164/rccm.201908-1581ST681243731573350
  27. 27. SARTELLI M., CATENA F., ABU-ZIDAN FM., ANSALONI L., BIFFL WL., BOERMEESTER MA., CERESOLI M., CHIARA O., COCCOLINI F., DE WAELE JJ. et al. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg. 2017; 12:22.10.1186/s13017-017-0132-7541873128484510
  28. 28. PAUL M., LADOR A., GROZINSKY-GLASBERG S., LEIBOVICI L. Beta lactam antibiotic monotherapy versus beta lactamaminoglycoside antibiotic combination therapy for sepsis. The Cochrane database of systematic reviews 2014; 1:CD003344.10.1002/14651858.CD003344.pub3651712824395715
  29. 29. PUGH R., GRANT C., COOKE RP., DEMPSEY G. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. The Cochrane database of systematic reviews 2015; 8:CD007577.10.1002/14651858.CD007577.pub3702579826301604
  30. 30. KWON JW., KIM YJ., YANG MS., SONG WJ., KIM SH., CHO SH., CHANG YS. Results of Intradermal Skin Testing with Cefazolin according to a History of Hypersensitivity to Antibiotics. Journal of Korean medical science. 2019; 34(50):e319.10.3346/jkms.2019.34.e319693555831880416
  31. 31. CASTELLS M., KHAN DA., PHILLIPS EJ. Penicillin Allergy. The New England journal of medicine 2019; 381(24):2338–2351.10.1056/NEJMra180776131826341
  32. 32. SEMLER MW., SELF WH., WANDERER JP., EHRENFELD JM., WANG L., BYRNE DW., STOLLINGS JL., KUMAR AB., HUGHES CG., HERNANDEZ A. et al. Balanced Crystalloids versus Saline in Critically Ill Adults. The New England journal of medicine 2018; 378(9):829–839.10.1056/NEJMoa1711584584608529485925
  33. 33. CORL KA., PRODROMOU M., MERCHANT RC., GAREEN I., MARKS S., BANERJEE D., AMASS T., ABBASI A., DELCOMPARE C., PALMISCIANO A. et al. The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study. Crit Care Med. 2019; 47(7):951–959.10.1097/CCM.0000000000003779657968330985449
  34. 34. LIU V., MOREHOUSE JW., SOULE J., WHIPPY A., ESCOBAR GJ. Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Annals of the American Thoracic Society. 2013; 10(5):466–473.10.1513/AnnalsATS.201304-099OC547542024004068
  35. 35. PURCAREA A., BOURGARIT A., SOVAILA S., GHIURA C., DIEMUNSCH P., ANDRES E. Brief report: Serial capillary lactate measurement predict the evolution of early sepsis. J Med Life. 2016; 9(1):74–78.
  36. 36. THEERAWIT P., NA PETVICHARN C., TANGSUJARITVIJIT V., SUTHERASAN Y. The Correlation Between Arterial Lactate and Venous Lactate in Patients With Sepsis and Septic Shock. J Intensive Care Med. 2018; 33(2):116–120.10.1177/088506661666316927502951
  37. 37. MONNET X., MARIK P., TEBOUL JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive care med. 2016; 42(12):1935–1947.10.1007/s00134-015-4134-126825952
  38. 38. LARA B., ENBERG L., ORTEGA M., LEON P., KRIPPER C., AGUILERA P., KATTAN E., CASTRO R., BAKKER J., HERNANDEZ G. Capillary refill time during fluid resuscitation in patients with sepsis-related hyperlactatemia at the emergency department is related to mortality. PloS one. 2017; 12(11):e0188548.10.1371/journal.pone.0188548570352429176794
  39. 39. LEACH R. Fluid management on hospital medical wards. Clinical medicine. 2010; 10(6):611–615.10.7861/clinmedicine.10-6-611495187221413489
  40. 40. STERN A., SKALSKY K., AVNI T., CARRARA E., LEIBOVICI L., PAUL M. Corticosteroids for pneumonia. The Cochrane database of systematic reviews 2017; 12:CD007720.10.1002/14651858.CD007720.pub3648621029236286
  41. 41. SOLOMON M., BARZILAI A., ELPHASY H., TRAU H., BAUM S. Corticosteroid Therapy in Combination with Antibiotics for Erysipelas. IMAJ 2018; 20(3):137–140.
  42. 42. MARIK PE., KHANGOORA V., RIVERA R., HOOPER MH., CATRAVAS J. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest 2017; 151(6):1229–1238.10.1016/j.chest.2016.11.03627940189
  43. 43. SHIN TG., KIM YJ., RYOO SM., HWANG SY., JO IJ., CHUNG SP., CHOI SH., SUH GJ., KIM WY. Early Vitamin C and Thiamine Administration to Patients with Septic Shock in Emergency Departments: Propensity Score-Based Analysis of a Before-and-After Cohort Study. Journal of clinical medicine 2019; 8(1). 9 Sepsis, a 2020 review for the internist 13710.3390/jcm8010102635224630654592
  44. 44. LITWAK JJ., CHO N., NGUYEN HB., MOUSSAVI K., BUSHELL T. Vitamin C, Hydrocortisone, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Analysis of Real-World Application. Journal of clinical medicine 2019; 8(4).10.3390/jcm8040478651800330970560
  45. 45. HAGER DN., HOOPER MH., BERNARD GR., BUSSE LW., ELY EW., FOWLER AA., GAIESKI DF., HALL A., HINSON JS., JACKSON JC. et al. The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial. Trials 2019; 20(1):197.10.1186/s13063-019-3254-2645123130953543
  46. 46. FOWLER AA., TRUWIT JD., HITE RD., MORRIS PE., DEWILDE C., PRIDAY A., FISHER B., THACKER LR., NATARAJAN R., BROPHY DF. et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019; 322(13):1261–1270.10.1001/jama.2019.11825677726831573637
  47. 47. FUJII T., LUETHI N., YOUNG PJ., FREI DR., EASTWOOD GM., FRENCH CJ., DEANE AM., SHEHABI Y., HAJJAR LA., OLIVEIRA G. et al. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial. JAMA. 2020; 323(5):423–431.10.1001/jama.2019.22176702976131950979
  48. 48. HEMILA H., CHALKER E. Vitamin C for preventing and treating the common cold. The Cochrane database of systematic reviews. 2013; 1:CD000980.10.1002/14651858.CD000980.pub4807815223440782
  49. 49. DONNINO MW., ANDERSEN LW., CHASE M., BERG KM., TIDSWELL M., GIBERSON T., WOLFE R., MOSKOWITZ A., SMITHLINE H., NGO L. et al. Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study. Crit Care Med. 2016; 44(2):360–367.10.1097/CCM.0000000000001572475467026771781
  50. 50. ANNANE D., BELLISSANT E., BOLLAERT PE., BRIEGEL J., KEH D., KUPFER Y., PIRRACCHIO R., ROCHWERG B. Corticosteroids for treating sepsis in children and adults. The Cochrane database of systematic reviews. 2019; 12:CD002243.10.1002/14651858.CD002243.pub4695340331808551
DOI: https://doi.org/10.2478/rjim-2020-0012 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 129 - 137
Submitted on: Apr 15, 2020
Published on: Aug 10, 2020
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2020 Adrian Purcarea, Silvia Sovaila, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.